Advancing excellence in laboratory medicine for better healthcare worldwide

Task Force Corporate Members (TF-CM)

Membership

NamePositionCountryTermTime in Office
Tricia RavalicoChair/ABBOTTUS1st2021 01 - 2023 12
Alessandro OrtisiSecretary/SIEMENS HealthineersIT1st2021 04 - 2023 12
Jean-Sébastien BlanchetMember/BECKMAN COULTERFR1st2019 04 - 2021 12
Vincent ChenMember/SNIBECN1st2021 04 - 2023 12
Brendan MeyerMember/BECTON DICKINSONUK1st2021 04 - 2023 12
Jordi Trafí PratsMember/ORTHO CLINICAL DIAGNOSTICSES1st2019 04 - 2021 12
Joseph PassarelliEB Corporate Representative/ROCHEUS1st2021 01 - 2023 12


TF-CM Meeting as Conference Call - April 2021

From left to right - top to bottom: 

Jordi Trafí Prats - Member/Ortho Clinical Diagnostics; Tricia Ravalico - Chair/Abbott; Jan Gorka - Corresponding Member/Diasys;  André Ziegler - EMD Corporate Member Rep/Roche; Vincent Chen/SNIBE; Joseph Passarelli - Executive Board Corporate Member Rep/Roche (TF-CM Past Chair); Michael Rottmann - SD Corporate Member Rep/Roche; Jean-Sébastien Blanchet - Member/Beckman Coulter; Colleen Strain - Transitional Secretary/Abbott;  Brendan Meyer - Member/Becton Dickinson Life Sciences;  Alessandro Ortisi - Secretary/Siemens Healthineers; Andy Quintenz - Corresponding Member/Bio-Rad;



Aim

The aim of IFCC TF-CM is to enable Corporate Members to make significant and growing contributions to the activities of IFCC, and to elevate key topics and priorities for the betterment of industry collaborations, laboratory medicine and health care.

Objectives

  • To assist IFCC in promotion of science, innovation, and advancement of the essential contribution of laboratory medicine to health care
  • To facilitate discussion among Corporate Members and identify common topics of interest and/or concern
  • To improve the engagement of Corporate Members with the IFCC
  • To serve as the “voice of industry” and be more accessible to all IFCC teams and leadership, enabling a more diverse understanding and appreciation of needs among corporate members and the IFCC
  • To increase awareness with other Corporate Members of IFCC TF-CM and to encourage their participation in IFCC activities

Accountability

The TF-CM will report directly to the IFCC Executive Board. The Corporate Representative of the Executive Board will be a liaison to the EB while serving as a member of TF-CM. The TF-CM will prepare reports to the Executive Board on meeting outcomes.

Background

The IFCC Task Force Corporate Members (TF-CM) was approved by the IFCC Executive Board and established in 2019 in order to strengthen the collaboration between IFCC and its Corporate Members. Similar to other task forces, the TF-CM reports directly to the IFCC Executive Board. The TF-CM consists of the chair and 6 other members, including the secretary, the Corporate Representative at the IFCC Executive Board, and 3 other members. Members are elected by the IFCC EB from nominations from the corporate representatives. The corporate representatives from each of the other divisions are also invited and encouraged to attend the TF-CM meetings. Memberships on the TF-CM are for 3 years with the possibility of extension for an additional 3 years.

Areas of Focus

  • The voice of corporate members within IFCC
  • High impact and frequency of conferences/congresses
  • Growth and sustainability of corporate members
  • Effective, timely and enhanced communications among IFCC, Conference Organizing Secretariat, and Corporate Members
  • Industry needs for IFCC involvement with regulators and clinical societies

Read the TF-CM article  extracted from the IFCC e-News-March 2021


List of Corresponding Members, nominated by Companies

NameCompany
Andy QuintenzBio-Rad Laboratories
Jan GorkaDiaSys
Gavin TuMaccura Biotechnology
Kalen OlsonSiemens Healthineers
Maurizio GramegnaTechnogenetics


Membership

Chair

Tricia RAVALICO
Director, Scientific Leadership and Education
Medical and Scientific Affairs
Core Diagnostics
Abbott
100 Abbott Park Road
CP-01-5
Abbott Park, IL 60064
USA
e-mail: Tricia.Ravalico@abbott.com

Secretary

Alessandro ORTISI

Associate Director / Global Clinical Marketing
Laboratory Diagnostics
SHS LD M&S CLS CM CA
Siemens Healthineers
Via Vipiteno, 4
20128 Milano
Italy
e-mail: alessandro.ortisi@siemens-healthineers.com



Members

Jean-Sébastien BLANCHET
Beckman Coulter Diagnostics
Director Medical and Scientific
France
e-mail: jblanchet@beckman.com

Vincent CHEN
Global Marketing Manager
SNIBE
No.23, Jinxiu East Road
Pingshan District
518122 Shenzhen
P.R. China
e-mail: vincent.chen@snibe.com

Brendan MEYER
Senior Manager, Medical Affairs Europe
Integrated Diagnostic Solutions
Becton Dickinson Life Sciences
Winnersh
UK
e-mail: Brendan.Meyer@bd.com

Jordi TRAFÍ PRATS
Senior Director Marketing EMEA
Ortho Clinical Diagnostics
Avenida Partenón 10, 3ª planta
Campo de las Naciones
28042 Madrid
Spain
e-mail: jordi.trafi@orthoclinicaldiagnostics.com

EB Corporate Representative

Joseph PASSARELLI
Scientific Relations, Research and Development
Roche Diagnostics Corporation
9115 Hague Road, PO Box 50416
Indianapolis, Indiana 46250-0416 - USA
Tel: +1 317 521 4206
Fax: +1 317 521 2324
Mobile: +1-317-625-7810
E-mail: joseph.passarelli@roche.com

 
Website developed by Insoft